Protective Factors and the Pathogenesis of Complications in Diabetes
Marc Gregory Yu(Joslin Diabetes Center), George L. King(Joslin Diabetes Center), Kyoungmin Park(Joslin Diabetes Center), Jialin Fu(Joslin Diabetes Center), Daniel Gordin(Helsinki University Hospital), Qian Li(Beijing Wuzi University)
Cited by 235
Related Papers
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
|New England Journal of Medicine|1994|3.8k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Retinopathy in Diabetes
|Diabetes Care|2004|1.1k
Activation of Protein Kinase C Isoforms and Its Impact on Diabetic Complications
|Circulation Research|2010|979